SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Zoom Communications, Inc. engages in the provision of a communications and collaboration platform. It operates through the following geographical segments: Americas, Asia Pacific, and Europe, Middle East, and Africa. The company was founded by Eric S. Yuan in 2011 and is headquartered in San Jose, CA.

Zoom Communications Inc. - Ordinary Shares - Class A

Oppenheimers upgrade to Outperform, citing improving uptake of Zooms AI platform, has fueled bullish interest in its shift toward enterprise workflows. Traders remain divided, with some viewing AI adoption and Zooms Anthropic stake as upside catalysts while skeptics question whether the business can sustain stronger growth.

Royal Caribbean Group is a cruise company, which engages in the ownership and operation of the following global cruise brands: Royal Caribbean International, Celebrity Cruises, and Silversea Cruises. The firm also holds interest in TUI Cruises GmbH, which operates the German brands TUI Cruises and Hapag-Lloyd Cruises. The company was founded by Arne Wilhelmsen in 1968 and is headquartered in Miami, FL.

Royal Caribbean Group

Royal Caribbeans upcoming third-quarter earnings report is the main focus, with traders positioning for a potential rebound after the recent pullback and citing strong bookings. Others are uneasy about weakness across cruise stocks and macro pressures, including fuel costs.

JasmyCoin is based on the ERC 20 standard. The token can also be used by an unspecified number of individuals and businesses to transfer tokens using digital devices as proof of value exchange or payment for services. By not limiting its usability, the token can have a wide range of purposes.

JasmyCoin

Traders are focused on concerns about JASMYs Upbit delisting and ongoing price weakness, with debate over whether the exchange news signals broader trouble or is being overstated. Some holders are buying the dip, while bears cite the delisting concerns and persistent declines as reasons for caution.

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Merck & Co Inc

Mercks partnership with Moderna drew attention after Phase 3 results showed their personalized cancer vaccine plus Keytruda reduced melanoma recurrence or death risk. Traders debated whether the benefitwhose overall-survival data remain immaturematched high expectations, with some viewing the share decline as a sell-the-news reaction.

CleanSpark, Inc. is a bitcoin mining technology company, which engages in the management of data centers. Its operations include College Park, Norcross, Washington, Sandersville, Dalton, and Massena. The company was founded by S. Matthew Schultz and Bryan Huber on October 15, 1987 and is headquartered in Henderson, NV.

Cleanspark Inc

CleanSpark is drawing attention for its steep selloff and underperformance despite Bitcoin holding up, with traders pointing to weakness across bitcoin miners and AI-infrastructure stocks. Discussion is split between short sellers expecting further declines and dip buyers citing the Meta data-center lease and Bitcoin holdings, while debt, execution, and management concerns weigh on sentiment.

Phathom Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel treatments for gastrointestinal diseases. The company was founded by Tadataka Yamada, David Socks, Azmi Nabulsi, Aditya Kohli, and Roger Ulrich on January 9, 2018 and is headquartered in Florham Park, NJ.

Phathom Pharmaceuticals Inc

BDR Pharmaceuticals lawsuit challenging the FDAs refusal to accept a generic application for VOQUEZNA has put Phathoms 10-year exclusivity through 2032 in focus, raising concern that generic competition could arrive earlier and weighing on shares. Traders disagree on the risk: some see a meaningful legal overhang, while others argue the FDA already ruled on the exclusivity question and the suit is against the agency, not Phathom.

Kyverna Therapeutics, Inc. is a cell therapy clinical-stage biotechnology company, which engages in the provision of treatments and potential cures for serious autoimmune diseases. The company was founded in June 2018 and is headquartered in Emeryville, CA.

Kyverna Therapeutics Inc.

Positive miv-cel clinical data in stiff person syndrome, including durable benefit across trial endpoints, alongside encouraging longer-term results in myasthenia gravis, is driving attention as Kyverna advances toward an SPS BLA. Many traders praise the results but are frustrated that the stock has struggled to hold gains; others cite small study sizes, serious adverse-event details, and possible dilution as reasons for caution.

Mastercard, Inc. is a technology company, which engages in the provision of payment solutions for the development and implementation of credit, debit, prepaid, commercial, and payment programs through its brands including Mastercard, Maestro, and Cirrus. It also offers cyber and intelligence solutions. The company was founded in November 1966 and is headquartered in Purchase, NY.

Mastercard Incorporated - Ordinary Shares - Class A

Mastercard Inc

Mastercards upcoming quarterly report is drawing attention as shares trade near record highs after a strong run. Traders are split between bullish breakout views and caution that guidance and consumer spending trends will matter more than the headline results.

Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. It operates through the Biopharmaceuticals and Exemplar segments. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.

Precigen Inc

Traders are debating whether FDA approval of Inovios INO-3107 could create competition for Precigens PAPZIMEOS in recurrent respiratory papillomatosis; the approval pathway and comparative clinical evidence remain disputed. Others point to PAPZIMEOS sales and anticipated quarterly results and PRGN-2009 updates as support for the companys outlook, while noting a lack of fresh news.

Visa, Inc. engages in the provision of digital payment services. It also facilitates global commerce through the transfer of value and information among a global network of consumers, merchants, financial institutions, businesses, strategic partners, and government entities. It offers debit cards, credit cards, prepaid products, commercial payment solutions, and global automated teller machines. The company was founded by Dee Hock in 1958 and is headquartered in San Francisco, CA.

Visa Inc - Ordinary Shares - Class A

Visa Inc

Visa is drawing attention ahead of its fiscal-year results, with traders focused on next-year margin guidance and whether strong payment trends can support further growth. The recent run to record highs has left the community split between bullish breakout sentiment and concerns that the stock is overbought or could pull back after the report.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

5 ETF Areas Trading at a 52-Week High

AI momentum, defensive investing and elevated energy prices are pushing several ETF areas to fresh 52-week highs in 2026.

Global X Funds - Global X MLP ETF

Neutral Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$54.58
Prev Close	$53.79
Open	$54.06
Dividend Yield	N/A
50-Day Moving Average	$55.52
Beta	N/A
Avg. Volume	222,598.43
PE Ratio	N/A

52-Week High	$58.00
52-Week Low	$47.01
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A

Feed

News

Sentiment

Fundamentals

Info

MLPA Fundamentals